Starting Dose for Cluster Headache: Sumatriptan 6 mg Subcutaneous
For acute treatment of cluster headache in adults, use sumatriptan 6 mg subcutaneous injection as the starting and standard dose. This is the only dose with Level A evidence and FDA approval for cluster headache 1, 2.
Dosing Specifics
Subcutaneous sumatriptan 6 mg is the gold standard for acute cluster headache treatment, providing rapid relief within 10-15 minutes in approximately 75% of patients 1, 2. The FDA label specifically demonstrates that at 15 minutes post-injection, 74-75% of patients achieve pain relief (reduction to mild or no pain) compared to 26-35% with placebo 1.
Why Not 12 mg?
While a 12 mg dose was studied, there was no statistically significant difference in efficacy between 6 mg and 12 mg doses, but the 12 mg dose caused more adverse events 3. The FDA trials confirmed this finding, making 6 mg the recommended dose 1.
Route of Administration Matters
- Subcutaneous is the only appropriate route for cluster headache 2, 4
- Intranasal sumatriptan and oral formulations are not effective for cluster headache 4
- The rapid onset required for cluster attacks (which peak within minutes) necessitates subcutaneous administration 5
Clinical Implementation
Instruct patients to:
- Administer 6 mg subcutaneously at the onset of a cluster attack
- Treat within 10 minutes of headache onset for optimal results 1
- Expect pain relief within 5-15 minutes, with most patients responding by 10 minutes 5
Do not exceed:
- Two 6 mg doses per 24-hour period
- The medication can be used for prolonged periods without loss of efficacy 4
Important Caveats
Contraindications include:
- Ischemic heart disease or previous myocardial infarction
- Prinzmetal angina
- Uncontrolled hypertension
- Concurrent use with ergotamines or methysergide 6
Common adverse events (occurring in ~30% of patients) include injection site reactions, with chest symptoms in 3-5% of patients 6. These are typically transient and mild to moderate in severity 1.
Alternative Only if Subcutaneous Fails
If subcutaneous sumatriptan is contraindicated or not tolerated, high-flow oxygen (100% at ≥12 L/min for 15 minutes) is the only other Level A recommendation for acute cluster headache treatment 2. Intranasal zolmitriptan 5-10 mg has some efficacy but is significantly inferior to subcutaneous sumatriptan 7.